Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01653405 · ClinicalTrials.gov registry record · NA
Improving Anticoagulation Control in VISN 1
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 1,260,576
- Enrollment target
NCT01653405: Completed NA study, sponsored by VA Office of Research and Development.
NCT01653405 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 1,260,576 participants, above the 1,382-participant average among 58,714 other NA trials with a reported enrollment target (91114% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01653405, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,260,576 participants
- Enrollment target
Study Summary
Over 100,000 VHA patients receive anticoagulants (blood thinners) each year to prevent blood clots (including strokes). Too much anticoagulation increases the risk of serious or even fatal bleeding, and too little anticoagulation fails to protect the patient against blood clots. VHA anticoagulation clinics vary widely on how much time their patients spend in the therapeutic range, the range within which they are protected from clots but not at excessive risk of bleeding. Anticoagulation clinics can improve anticoagulation control by following several relatively simple procedures, including following-up promptly when patients are out of range and focusing on educating and supporting patients with poor control. In this study, the investigators will promote these practices at the anticoagulation clinics of the New England VA region, with a goal of improving anticoagulation control.
Primary Outcome
We compared TTR after the intervention to before the intervention. We used a difference in differences analysis to compare the absolute percentage change over time in the intervention group vs. the control group.
Interventions
- OTHER Multifaceted behavioral intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,260,576 participants |
| Start Date | 2014-10-01 |
| Est. Completion | 2016-09-30 |
| Phase | NA |
What the finished NCT01653405 record still lists
NCT01653405 is an interventional study that assigns participants to a tested intervention. Its 1,260,576 participants enrollment target places it among the larger protocols in the corpus, above the 1,382-participant average among 58,714 other NA trials with a reported enrollment target (91114% higher).
The record links to 0 conditions, and to 1 intervention - of which Multifaceted behavioral intervention is the first listed.
NCT01653405 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01653405 about?
NCT01653405 is a clinical study titled "Improving Anticoagulation Control in VISN 1". Over 100,000 VHA patients receive anticoagulants (blood thinners) each year to prevent blood clots (including strokes). Too much anticoagulation increases the risk of serious or even fatal bleeding, and too little anticoagulation fails to protect the patient against blood clots. VHA anticoagulation ...
What is the current status of trial NCT01653405?
This trial is currently completed. It is a NA study. The enrollment target is 1,260,576 participants. The study started on 2014-10-01. Estimated completion is 2016-09-30.
What interventions are being tested in trial NCT01653405?
The interventions under investigation include: Multifaceted behavioral intervention (OTHER).
Who is sponsoring clinical trial NCT01653405?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01653405's enrollment target sits among peer trials
1,260,576 1st of 2000 higher than 2,000 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07022951 · 1,200,000 participants
The Million Anesthesia Cases Study (MACS) - a Cohort Study of Preoperative Fasting and Perioperative Outcomes
- NCT05066763 · 1,000,000 participants
Parkinson's Foundation Surveys
- NCT07075341 · 1,000,000 participants
Healthy Living BEYOND Weight Study
- NCT07224685 · 1,000,000 participants
A Study of Mayo Clinic CV Research Heart & Voice Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI